1. The NIH COVID-19 Treatment Guidelines Panel recommends use of dexamethasone 6 mg/d for up to 10 days in patients with COVID-19 who

2. In late August, FDA expanded its emergency use authorization for remdesivir to include

3. In a recently published COVID-19 clinical trial conducted at 105 hospitals, which of the following adverse effects of remdesivir were more common among patients on the drug than those receiving standard care?

4. According to a living systematic review and network meta-analysis of studies with at least 100 participants with COVID-19, lopinavir–ritonavir produced a significant difference in which of the following outcomes compared with standard care?

5. According to FDA, clinical benefits of COVID-19 convalescent plasma are most likely

Evaluation Questions

6. To what extent did the program meet objective #1?

7. Rate the effectiveness of how well the program related to your educational needs:

8. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:

9. Rate the quality of the faculty:

10. Rate the effectiveness and the overall usefulness of the material presented:

11. Rate the appropriateness of the examination for this activity:

12. Rate the effectiveness of how well the activity related to your practice needs:

13. Rate the effectiveness of how well the activity will help you improve patient care:

14. Will the information presented cause you to change your practice?

15. Are you committed to making these changes?

16. As a result of this activity, did you learn something new?

17. What is your practice setting or area of practice?

18. How many years have you been in practice?

« Return to Activity